WallStreetZenWallStreetZen

NASDAQ: EVAX
Evaxion Biotech A Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EVAX

Based on 2 analysts offering 12 month price targets for Evaxion Biotech A

Min Forecast
$6.00+359.77%
Avg Forecast
$10.00+666.28%
Max Forecast
$14.00+972.8%

Should I buy or sell EVAX stock?

Based on 2 analysts offering ratings for Evaxion Biotech A.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although EVAX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates EVAX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their EVAX stock forecasts and price targets.

EVAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-02
lockedlocked$00.00+00.00%2025-02-04

1 of 1

Forecast return on equity

Is EVAX forecast to generate an efficient return?

Company
-212.26%
Industry
153.19%
Market
81.87%
EVAX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EVAX forecast to generate an efficient return on assets?

Company
28.09%
Industry
36.07%
EVAX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EVAX earnings per share forecast

What is EVAX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.41
Avg 2 year Forecast
-$1.39
Avg 3 year Forecast
$0.12

EVAX revenue forecast

What is EVAX's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$5.5M+64.32%
Avg 2 year Forecast
$7.2M+113.97%
Avg 3 year Forecast
$67.8M+1,927.21%
EVAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVAX revenue growth forecast

How is EVAX forecast to perform vs Biotechnology companies and vs the US market?

Company
38.14%
Industry
65.48%
Market
10.37%
EVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVAX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EVAX$1.31$10.00+666.28%Strong Buy
ZVSA$0.70N/AN/A
ELAB$2.68N/AN/A
TNFA$0.17N/AN/A
ENTO$0.35N/AN/A
View Top Biotech Stocks

Evaxion Biotech A Stock Forecast FAQ

Is Evaxion Biotech A Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EVAX) stock is to Strong Buy EVAX stock.

Out of 2 analysts, 1 (50%) are recommending EVAX as a Strong Buy, 1 (50%) are recommending EVAX as a Buy, 0 (0%) are recommending EVAX as a Hold, 0 (0%) are recommending EVAX as a Sell, and 0 (0%) are recommending EVAX as a Strong Sell.

If you're new to stock investing, here's how to buy Evaxion Biotech A stock.

What is EVAX's earnings growth forecast for 2025-2027?

(NASDAQ: EVAX) Evaxion Biotech A's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Evaxion Biotech A's earnings in 2025 is -$10,567,000.On average, 2 Wall Street analysts forecast EVAX's earnings for 2025 to be -$98,533,431, with the lowest EVAX earnings forecast at -$194,962,946, and the highest EVAX earnings forecast at -$2,103,917. On average, 2 Wall Street analysts forecast EVAX's earnings for 2026 to be -$97,130,820, with the lowest EVAX earnings forecast at -$192,859,029, and the highest EVAX earnings forecast at -$1,402,611.

In 2027, EVAX is forecast to generate $8,415,667 in earnings, with the lowest earnings forecast at $8,415,667 and the highest earnings forecast at $8,415,667.

What is EVAX's revenue growth forecast for 2025-2027?

(NASDAQ: EVAX) Evaxion Biotech A's forecast annual revenue growth rate of 38.14% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Evaxion Biotech A's revenue in 2025 is $3,344,000.On average, 2 Wall Street analysts forecast EVAX's revenue for 2025 to be $385,367,405, with the lowest EVAX revenue forecast at $34,363,972, and the highest EVAX revenue forecast at $736,370,838. On average, 2 Wall Street analysts forecast EVAX's revenue for 2026 to be $501,784,128, with the lowest EVAX revenue forecast at $68,727,945, and the highest EVAX revenue forecast at $934,840,311.

In 2027, EVAX is forecast to generate $4,754,150,391 in revenue, with the lowest revenue forecast at $4,754,150,391 and the highest revenue forecast at $4,754,150,391.

What is EVAX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EVAX) forecast ROA is 28.09%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is EVAX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EVAX price target, the average EVAX price target is $10.00, with the highest EVAX stock price forecast at $14.00 and the lowest EVAX stock price forecast at $6.00.

On average, Wall Street analysts predict that Evaxion Biotech A's share price could reach $10.00 by Apr 2, 2026. The average Evaxion Biotech A stock price prediction forecasts a potential upside of 666.28% from the current EVAX share price of $1.31.

What is EVAX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EVAX) Evaxion Biotech A's current Earnings Per Share (EPS) is -$10.00. On average, analysts forecast that EVAX's EPS will be -$1.41 for 2025, with the lowest EPS forecast at -$2.78, and the highest EPS forecast at -$0.03. On average, analysts forecast that EVAX's EPS will be -$1.39 for 2026, with the lowest EPS forecast at -$2.75, and the highest EPS forecast at -$0.02. In 2027, EVAX's EPS is forecast to hit $0.12 (min: $0.12, max: $0.12).

What is EVAX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EVAX) forecast ROE is -212.26%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.